I think the most important details have already been announced. Same trial as before except the patients get dosed for two cycles instead of one and the requirements for enrolling are stricter. Last trial was about fixing the mistakes of the trial before it. This one is about fixing the mistakes of the last trial.
Market Data 
Markets
AI
